Mannatech, Incorporated (MTEX)

Over the past six months, Mannatech's stock experienced several events and fluctuations. In Q3 2025, the company reported a GAAP EPS of $1.01 and revenue of $29.2 million, achieving a net income of $1.9 million, despite an 8.1% year-over-year decline in net sales. The second quarter 2025 earnings were released reporting a GAAP EPS of -$2.27 and revenue of $25.7 million. Peter Griscom was promoted to Chief Operating Officer but resigned shortly after. The company held its Annual General Meeting on June 3, 2025. The stock traded between a 52-week high of $12.45 and a 52-week low of $6.90, with a closing price around $7.39 to $7.64 as of early February 2026, reflecting a decline of 3.26% over the past six months.

Information regarding specific demand seasonality for Mannatech, Inc. products and services is not directly provided in the available search results. While data exists to identify seasonal patterns in MTEX's monthly stock returns, the actual seasonal trends for product demand are not detailed.

Mannatech, Inc. is a global health and wellness company that develops, markets, and sells nutritional supplements, skincare, anti-aging, and weight-management products, primarily through network marketing and e-commerce. The company operates in the Health Technology sector, focusing on pharmaceuticals, medicinal chemicals, and botanical products. Its product portfolio includes integrative health, targeted health, wealth and fitness, skin care, essentials, and home products, featuring patented glyconutrient technology in products like Ambrotose® Complex/LIFE to support cellular communication and immune function. Mannatech also offers weight management systems like the TruHealth™ 30-Day System.

Mannatech operates in three main regions: The Americas, including the United States, Canada, and Mexico, which historically generates the majority of the company's revenue. Europe/Middle East/Africa (EMEA), including countries such as Austria, Belgium, the Czech Republic, and the United Kingdom. Asia/Pacific, encompassing Australia, Japan, New Zealand, and China, which was the largest revenue driver in Q3 2025, contributing over 64% of quarterly revenue.

In the past year, specific events directly impacting Mannatech's brand reputation were not prominently detailed in the provided search results. Historically, the company faced regulatory scrutiny and lawsuits regarding unproven health claims. Mannatech's Mission 5 Million (M5M) Foundation, which links product purchases to nutritional support for children, is an ongoing initiative aimed at enhancing the brand's image.

Mannatech's ownership structure is characterized by a significant insider stake. J. Stanley Fredrick, the Chairman of the Board, holds a substantial personal stake in the company. Key institutional shareholders include BlackRock, Inc., The Vanguard Group, Inc., and Renaissance Technologies LLC. Insiders hold approximately 49.54% of the shares, institutional investors hold about 13.36%, and the retail/public float accounts for roughly 37.10%.